Aerinaze desloratadine/pseudoephedrine regulatory update

CHMP issued a positive opinion for the approval of Aerinaze, a combination of 2.5 mg desloratadine and 120 mg pseudoephedrine to treat seasonal allergic rhinitis accompanied by nasal congestion. ...